Harvoni (ledipasvir/sofosbuvir)

pCPA File Number: 20737
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Hepatitis C
Sponsor/Manufacturer:
Gilead Sciences Canada Inc.
CDA-AMC Project Number:
SR0395-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: